Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Expand current view of PTSC potential..Michmagic

RE: Expand current view of PTSC potential..Michmagic

posted on Mar 01, 2006 05:48PM
Qualcomm has products....PTSC does not. Revenues may or may be recurring. If recurring, the amounts per year are likely much less than a ONE TIME payment for a license. So that`s what makes this more like a RAMBUS market cap than a Qualcomm or other design, mfg, selling organization with revenue growth that justifies their PE ratio and market cap.

I`m still thinking resistance at market cap $2Billion. $7/sh.......but hope irrational exuberance prevails and I am wrong!!

biomedman

Share
New Message
Please login to post a reply